<DOC>
	<DOCNO>NCT01146041</DOCNO>
	<brief_summary>The purpose bioequivalence study compare test Rivastigmine 1.5 mg Capsules Dr.Reddy 's Laboratories Limited reference Exelon 1.5 mg Novartis Healthy Subjects Under Fed Conditions .</brief_summary>
	<brief_title>Bioequivalence Study Rivastigmine Capsules 1.5 mg Dr.Reddy 's Under Fed Conditions</brief_title>
	<detailed_description>Bioequivalence study Rivastigmine Capsules 1.5 mg Exelon 1.5 mg This single center , single-dose , open-label , randomize , 2-way crossover bioequivalence study , perform fed condition . The treatment phase separate washout period 7 day .</detailed_description>
	<mesh_term>Rivastigmine</mesh_term>
	<criteria>Inclusion criterion Subjects enrol study member community large . The recruitment advertisement may use various medium type ( e.g . radio , newspaper , Anapharm Inc . Web site , Anapharm Inc. volunteer 's database ) . Subjects must meet follow criterion order include study : Male female , smoker nonsmoker , 18 year age old . Capable consent Exclusion criterion Subjects follow applies exclude study : Clinically significant illness within 4 week prior administration study medication . Clinically significant surgery within 4 week prior administration study medication . Any clinically significant abnormality find medical screening . Any reason , opinion Medical SubInvestigator , would prevent subject participate study . Abnormal laboratory test judge clinically significant . Positive test hepatitis B , hepatitis C , HN screen . BCG abnormality ( clinically significant ) vital sign abnormality ( systolic blood pressure low 90 140 mmHg , diastolic blood pressure low 50 90 mrnHg , heart rate less 50 100 bpm ) screening . BMI ≥30.0 . History significant alcohol abuse within six month prior screen visit indication regular use fourteen unit alcohol per week ( l Unit = 150 mL wine , 360 mL beer , 45 mL 40 % alcohol ) . History drug abuse use illegal drug : use soft drug ( marijuana ) within 3 month prior screen visit hard drug ( cocaine , phencyclidine [ PCP ] crack ) within 1 year prior screen visit positive urine drug screen screen . History allergic reaction rivastigmine relate drug . History allergic reaction heparin . Use drug know induce inhibit hepatic drug metabolism ( examples inducer : barbiturate , carbamazepine , phenytoin , glucocorticoid , rifampin/rifabutin ; examples inhibitor : antidepressant , cimetidine , diltiazem , erythromycin , ketoconazole , MAO inhibitor , neuroleptic , verapamil , quinidine ) within 30 day prior administration study medication . Use investigational drug participation investigational study within 30 day prior administration study medication . Clinically significant history presence clinically significant gastrointestinal pathology ( e.g . chronic diarrhea , inflammatory bowel disease ) , unresolved gastrointestinal symptom ( e.g . diarrhea , vomit ) , liver kidney disease , condition know interfere absorption , distribution , metabolism , excretion drug . Any clinically significant history presence clinically significant neurological , endocrinal , cardiovascular , pulmonary , hematologic , immunologic , psychiatric , metabolic disease . Use prescription medication within 14 day prior administration study medication overthecounter product ( include natural food supplement , vitamin , garlic supplement ) within 7 day prior administration study medication , except topical product without systemic absorption hormonal contraceptive . Difficulty swallow study medication . Smoking 25 cigarette per day . Any food allergy , intolerance , restriction special diet could , opinion Medical SubInvestigator , contraindicate subject 's participation study . A depot injection implant drug ( hormonal contraceptive ) within 3 month prior administration study medication . Donation plasma ( 500 mL ) within 7 day prior drug administration . Donation loss whole blood ( exclude volume blood drawn screening procedure study ) prior administration study medication follow : 50 mL 300 mL whole blood within 30 day , 301 mL 500 mL whole blood within 45 day , 500 mL whole blood within 56 day prior drug administration . History ulcer disease . History asthma obstructive pulmonary disease . Use nonsteroidal antiinflammatory drug ( e.g . Motrin® , Advil® ) within 14 day prior drug administration . History seizure , urinary obstruction benign prostatic hypertrophy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Bioequivalence</keyword>
</DOC>